MHR
BMY icon

Matthew Hamilton Rosenberg’s Bristol-Myers Squibb BMY Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$121K Buy
1,933
+184
+11% +$11.6K 0.02% 320
2026
Q2 		$101K Buy
1,749
+1,053
+151% +$60.5K 0.02% 343
2026
Q1 		$42.2K Hold
696
– – 0.01% 443
2025
Q4 		$37.5K Hold
696
– – 0.01% 462
2025
Q3 		$31.4K Sell
696
-3,103
-82% -$145K 0.01% 482
2025
Q2 		$176K Buy
3,799
+2,153
+131% +$106K 0.04% 225
2025
Q1 		$100K Sell
1,646
-59
-3% -$3.44K 0.03% 315
2024
Q4 		$96.4K Buy
1,705
+694
+69% +$38.8K 0.03% 320
2024
Q3 		$52.3K Hold
1,011
– – 0.01% 419
2024
Q2 		$41.8K Sell
1,011
-1,646
-62% -$73.7K 0.01% 447
2024
Q1 		$141K Buy
2,657
+373
+16% +$19K 0.04% 249
2023
Q4 		$117K Sell
2,284
-282
-11% -$14.8K 0.04% 274
2023
Q3 		$149K Sell
2,566
-423
-14% -$25.9K 0.05% 220
2023
Q2 		$191K Buy
2,989
+99
+3% +$6.64K 0.06% 179
2023
Q1 		$200K Sell
2,890
-133
-4% -$9.38K 0.06% 185
2022
Q4 		$218K Buy
3,023
+205
+7% +$15.5K 0.07% 165
2022
Q3 		$200K Buy
2,818
+45
+2% +$3.26K 0.08% 159
2022
Q2 		$213K Buy
2,773
+226
+9% +$17.2K 0.08% 158
2022
Q1 		$186K Hold
2,547
– – 0.07% 197
2021
Q4 		$159K Sell
2,547
-565
-18% -$33.1K 0.06% 226
2021
Q3 		$184K Buy
3,112
+543
+21% +$35.8K 0.07% 176
2021
Q2 		$172K Buy
2,569
+272
+12% +$17.7K 0.09% 160
2021
Q1 		$145K Buy
2,297
+357
+18% +$22.2K 0.08% 179
2020
Q4 		$114K Buy
1,940
+153
+9% +$9.41K 0.07% 212
2020
Q3 		$108K Sell
1,787
-60
-3% -$3.61K 0.08% 188
2020
Q2 		$109K Buy
1,847
+2
+0.1% +$120 0.09% 170
2020
Q1 		$103K Buy
+1,845
New +$113K 0.1% 114

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Matthew Hamilton Rosenberg's BMY Position: Q3 2026 in Review

Matthew Hamilton Rosenberg increased its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, buying an estimated $11.6K and bringing the position to 1,933 shares worth $121K. The position accounts for 0.02% of the portfolio, ranked #320.

Matthew Hamilton Rosenberg first reported a position in BMY in Q1 2020 and has held it in 27 quarters since. The position peaked at $218K in Q4 2022. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Matthew Hamilton Rosenberg held 1,933 shares of Bristol-Myers Squibb worth $121K as of Q3 2026.
  • Matthew Hamilton Rosenberg bought 184 Bristol-Myers Squibb shares in Q3 2026, an estimated $11.6K.
  • Bristol-Myers Squibb made up 0.02% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #320 holding.
  • Matthew Hamilton Rosenberg first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 27 quarters since.
  • Matthew Hamilton Rosenberg's Bristol-Myers Squibb position peaked at $218K in Q4 2022.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.